Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.
暂无分享，去创建一个
A. Jacobs | C. Kramm | E. Chiocca | N. Rainov | M. Sena-Esteves | X. Breakefield | P. Pechan | M. Aghi | U. Herrlinger | F. H. Barnett | M. Chase | X. Breakefield | Ulrich Herrlinger | N. G. Rainov | Christof Maria Kramm | Manish K. Aghi | Peter A. Pechan | Chiocca Ea